Patient info Open main menu

Adalat LA 30 mg prolonged-release tablets – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
30 mg
Contains active substance:
ATC code:

Patient leaflet - Adalat LA 30 mg prolonged-release tablets

1 What Adalat LA is and what it is used for

Adalat LA contains nifedipine, which belongs to a group of medicines called calcium antagonists.

Adalat LA is used to treat high blood pressure or angina

(chest pain).

For high blood pressure: Adalat LA works by relaxing and expanding the blood vessels. This makes the blood flow more easily and lowers blood pressure. Lower blood pressure reduces the strain on your heart.

For angina: Adalat LA works by relaxing and expanding the arteries supplying the heart. This allows more blood and oxygen to reach the heart and decreases the strain on it. Your angina attacks will be less severe and less frequent if there is less strain on the heart.

2 What you need to know before you take Adalat LA

Do not take Adalat LA:

  • If you have had a heart attack within the last month. • If you get a sudden angina attack. Adalat LA will not help

    relieve symptoms of angina quickly.

  • If you have unstable angina.
  • If you are allergic to nifedipine, any other similar medicines

    (known as dihydropyridines) or any of the other ingredients of this medicine (listed in section 6).

  • If you are taking rifampicin, an antibiotic.
  • If you have a liver disease that prevents your liver from

    working properly.

  • If you have inflammation of the bowel or intestines,

    such as Crohn’s disease.

  • If you have an obstruction or narrowing in your

    intestines, or have had this in the past.

  • If you have ever had an obstruction in the gullet

    (the oesophagus - the tube connecting the throat to the stomach).

  • If you have been told that you have a narrowing of the

    aortic heart valve (stenosis).

  • If you have ever had a collapse caused by a heart

    problem (cardiogenic shock), during which you became breathless, pale and had a cold sweat and dry mouth. • If you have a “Kock pouch” (a surgically constructed

    intestinal reservoir with an opening through the abdominal wall) in your gut.

    • If your blood pressure continues to rise despite treatment

      (malignant hypertension).

➔Tell your doctor and do not take Adalat LA if any of these

apply to you.

Warnings and precautions

Talk to your doctor before taking Adalat LA

  • If you have low blood pressure and you were prescribed

    Adalat LA for your angina. Your blood pressure may be decreased further by this treatment.

  • If you have a heart condition where your heart cannot cope

    with increased strain (poor cardiac reserve).

  • If you are pregnant.
  • If you are a diabetic. The treatment for your diabetes may

    need to be adjusted. If you have any questions about this, ask your doctor.

  • If you are on kidney dialysis. If you have a very high blood

    pressure and a low blood volume, you might experience a sudden drop in blood pressure when you take Adalat LA. • If your liver is not working properly. Your doctor may

    need to do some blood tests. You may also be given a lower dose of Adalat LA.

➔Talk to your doctor before you take Adalat LA if any of

these apply to you.

Tell your doctor:

  • If your chest pain (angina) gets worse (comes on more

    often or more severely) over a matter of hours or days. You may be advised not to take Adalat LA.

  • If you have chest pains after taking your first dose of

    Adalat LA. Your doctor may wish to change your treatment. • If you notice increased breathlessness.

  • If you notice swelling of the ankles.

➔Tell your doctor before you take the next dose if any of

these apply to you.

Also tell your doctor:

  • If you are giving a urine sample. Adalat LA may interfere

    with the results of certain urine tests.

  • If you are to have a barium contrast x-ray (barium meal).

    These tablets may affect the results of the test. • If you are a man who has been unable to father a child

    by in vitro fertilisation. Drugs like Adalat LA have been shown to impair sperm function.

Other medicines and Adalat LA

Tell your doctor if you are taking, have recently taken or might take any other medicines.

Some medicines may affect the way Adalat LA works. Tell your doctor if you are taking:

  • Other medicines to treat high blood pressure. • Rifampicin (an antibiotic).
  • Cimetidine (to treat stomach ulcers).
  • Digoxin, diltiazem, quinidine or beta-blockers (to treat

    heart conditions).

  • Quinupristin/dalfopristin (a combination antibiotic). • Phenytoin, carbamazepine or valproic acid (to treat

    epilepsy).

  • Cisapride (to treat reduced movements of the gullet and

    stomach).

  • Magnesium sulphate injections during pregnancy (may

    cause a severe fall in blood pressure).

  • Erythromycin (an antibiotic).
  • Ketoconazole, itraconazole or fluconazole (anti-fungal

    medicines).

  • Indinavir, nelfinavir, ritonavir, saquinavir or amprenavir

    (to treat HIV).

  • Fluoxetine or nefazodone (to treat depression). • Tacrolimus (to prevent the rejection of transplanted organs). • Phenobarbital (usually used to treat insomnia or anxiety).

    Adalat LA with food and drink

    You can take Adalat LA with or without food.

    Do not drink grapefruit juice or eat grapefruit while taking Adalat LA.

    Do not start taking Adalat LA within 3 days of

    drinking grapefruit juice or eating grapefruit. Tell your doctor if you have had grapefruit or grapefruit juice in this time. Also, do not drink grapefruit juice or eat grapefruit whilst taking Adalat LA. Grapefruit juice is known to increase the blood levels of the active ingredient, nifedipine. This effect can last for at least 3 days.

    Adalat LA 30 contains 9.4 mg of sodium (main component of cooking/table salt). This is less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium-free’. Increasing the daily dose to 90 mg nifedipine results in an intake of 28.2 mg sodium. This is equivalent to 1.41 % of the recommended maximum daily dietary intake of sodium for an adult. Tell your doctor if you are on a low-salt diet.

    Pregnancy and breast-feeding

    If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.

    You may be able to use Adalat LA but only after special consideration and agreement by your doctor.

    Adalat LA has been shown to pass into breast milk in small amounts. It is not known if nifedipine might impact your baby. If you are breastfeeding or about to start breastfeeding, talk to your doctor before taking nifedipine or if you have any concerns about your baby whilst taking this medicine.

    Driving and using machines

    Adalat LA may make you feel dizzy, faint, extremely tired or have visual disturbances. Do not drive or operate machinery if you are affected in this way.

    This may be more likely when you first start treatment, if you change tablets, or if you have drunk alcohol.

3 How to take Adalat LA

Adalat LA is specially formulated so that you only have to take one dose each day.

Always take this medicine exactly as your doctor has told you. Check with your doctor if you are not sure.

  • Dose for high blood pressure: the usual dose is 1 tablet, once a day.
  • Dose for angina: the dose depends on your individual requirements. Your doctor will decide how much you should take. • Swallow the tablets whole. Do not bite, chew or break them – if you do they will not work properly. If you have difficulty swallowing tablets, consult your doctor as he or she may wish to change your medicine.
  • Continue to take these tablets for as long as your doctor has told you to.

Take your dose at the same time each day, preferably in the morning.

Take your tablets with a glass of water. Do not take them with grapefruit juice.

You can take Adalat LA with or without food.

You may see what looks like a complete tablet in the toilet or in your stools. This is normal – it’s the outer shell of the tablet which is not digested by the body.

Use in children and adolescents: Adalat LA is not recommended for use in children and adolescents below 18 years of age, because there are only limited data on the safety and efficacy in this population.

If you take more Adalat LA than you should

➔Get medical help immediately. If possible, take your tablets or the box with you to show the doctor.

Taking too many tablets may cause your blood pressure to become too low and your heartbeats to speed up or slow down. It may also lead to an increase in your blood sugar level or an increase in the acidity of your blood, swelling in the lungs, low blood oxygen levels and disturbances in consciousness, possibly leading to unconsciousness.

June

2026

REVISED

If you forget to take Adalat LA

Take your normal dose immediately and continue taking your tablets at the usual time of day, waiting at least 12 hours before taking the next dose.

Do not take a double dose to make up for a forgotten dose. If you have any further questions on the use of this medicine, ask your doctor.

4 Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Serious side effects

If you notice:

  • Severe, sudden generalised allergic reaction including very

    rarely life-threatening shock (e.g. difficulty in breathing, drop of blood pressure, fast pulse), swelling (including potentially life-threatening swelling of the airway)

  • other allergic reactions causing swelling under the skin

    (possibly severe and including swelling of the larynx that may result in a life-threatening outcome)

  • fast heart beat (tachycardia)
  • shortness of breath (frequency not known) or difficulty breathing • mild to moderate allergic reactions
  • itching (possibly severe), a rash or hives

➔Contact your doctor immediately and do not take the

next dose as these may be the first signs of allergic reaction which may become severe.

If you develop:

  • a skin reaction or blistering/peeling of the skin and/or

    mucosal reactions (in the mouth/nose or at the penis/vagina) (Toxic Epidermal Necrolysis)

➔Contact your doctor immediately before you continue

treatment as these may be signs of a severe reaction.

Less serious side effects

Apart from the side effects listed above, these are the other side effects of Adalat LA, starting with the more common ones:

Common side effects

(These may affect up to 1 in 10 people)

  • headache
  • flushing
  • general feeling of being unwell
  • constipation
  • swelling, particularly of the ankles and legs

Uncommon side effects

(These may affect up to 1 in 100 people)

  • stomach pain (abdominal pain)
  • unspecific pain
  • chills
  • low blood pressure when standing up (symptoms include

    fainting, dizziness, light headedness, occasional palpitations, blurred vision and sometimes confusion)

  • fainting
  • irregular heartbeat (palpitations)
  • dry mouth
  • indigestion or upset stomach
  • wind (flatulence)
  • feeling sick (nausea)
  • muscle cramps
  • joint swelling
  • sleep disorders
  • anxiety or nervousness
  • reddening of the skin
  • nose bleeds
  • nasal congestion
  • sensation of spinning or whirling motion (vertigo) • migraine
  • dizziness
  • trembling
  • increase in the need to pass water (urinate)
  • painful or difficult urination

    • inability to achieve or maintain an erection (impotence) • blurred vision
    • temporary increase in certain liver enzymes

Rare side effects

(These may affect up to 1 in 1,000 people)

  • pins and needles
  • inflammation of the gums, tender or swollen gums, bleeding

    gums

Other side effects

(Frequency not known: frequency cannot be estimated from the available data)

  • stomach pain or distress caused by a mass of foreign material

    found in the stomach which may require surgery for removal • difficulty swallowing

  • abdominal pain, caused by obstruction of the gut or ulcers in the gut • vomiting
  • a reduction in the number of white blood cells (leucopenia) • a more severe decrease in a specific class of white blood cell

    (agranulocytosis)

  • depression
  • increased blood sugar (hyperglycaemia)
  • decreased skin sensitivity (hypoaesthesia)
  • drowsiness (somnolence)
  • eye pain
  • chest pain (angina pectoris)
  • heartburn or indigestion (gastroesophageal sphincter

    insufficiency)

  • yellowing of the whites of the eyes or skin (jaundice) • sensitivity to light (photosensitivity allergic reaction) • small, raised areas of bleeding in the skin (palpable purpura) • joint pain
  • muscle pain

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below). By reporting side effects you can help provide more information on the safety of this medicine.

United Kingdom

Yellow Card Scheme

Website: www.mhra.gov.uk/yellowcard

Malta

ADR Reporting

Website: www.medicinesauthority.gov.mt/adrportal

5 How to store Adalat LA

Keep this medicine out of the sight and reach of children. Do not store above 30°C.

Store your medicine in its original container. Protect from strong light and only remove the tablet from the blister strip when you are about to take it.

Do not use this medicine after the expiry date which is stated on both the outer carton and on each blister strip of tablets after EXP. The expiry date refers to the last day of that month. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6 Contents of the pack and other information

What Adalat LA contains

Adalat LA tablets contain the active ingredient, nifedipine. Adalat LA tablets also contain propylene glycol, cellulose acetate, hypromellose, hydroxypropylcellulose, polyethylene oxide, macrogol, magnesium stearate, black printing ink Opacode (containing iron oxide black (E172) and shellac), titanium dioxide (E171), iron oxide (E172) and sodium chloride (see section 2).

What Adalat LA looks like and contents of the pack

Each prolonged-release tablet contains 30 mg of nifedipine. Each tablet is pink and round with a laser hole on one side and marked ‘Adalat 30’.

Each pack contains 28 tablets. Each tablet has the day of the week printed next to it to remind you when to take it.

Marketing Authorisation Holder and Manufacturer

Marketing authorisation holder:

Bayer plc, 400 South Oak Way, Reading, RG2 6AD Manufacturer:

Bayer AG, Leverkusen, Germany

This leaflet was last revised in June 2026.

Product licence number: PL 00010/0174

B

305x346-16866_15923

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 00010/0174

Last revision stated in the text: June 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Adalat LA 30 mg prolonged-release tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Nifedipine
Strength 30 mg
Pharmaceutical form Modified-release tablet
Pink, round, convex tablet with a laser hole on one side and marked with Adalat 30.
How is it taken Oral
Excipients Polyethylene oxide, Hypromellose (5 cp), Magnesium stearate, Sodium chloride, Ferric oxide, red (E172), Cellulose acetate, Macrogol (3350), Hydroxypropylcellulose, Hypromellose (3 cp), Propylene glycol, Titanium dioxide (E171), Polish and Print, Black ink for printing Opacode S-1-17823 (Contains: iron oxide black (E172) and Shellac)
Pack sizes 28 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life PP / Al foil blister packs: 4 years PVC / PVDC / Al foil blister packs: 3 years
Drug group (ATC) Selective calcium channel blockers with mainly vascular effect, dihydropyridine derivatives
  1. C Cardiovascular system drugs
    1. C08 Calcium channel blockers
      1. C08C Selective calcium channel blockers with mainly vascular effects
        1. C08CA Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects
          1. C08CA05 nifedipine
Marketing authorisation PL 00010/0174
Marketing authorisation holder Bayer plc
Codes GTIN 5010605005107 · BNF 02060200

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.